Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and pathological services business of Vimta Labs.

Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025.

Powered by Capital Market - Live News

Click here to connect with us on WhatsApp

Disclaimer: No Business Standard Journalist was involved in creation of this content

LIVE: SAD sends legal notice to CBFC over Kangana's movie Emergency, seeks to prevent release

Google releases Gmail Q&A feature on Android, coming soon to iOS: Know more

Garden Reach inks MoU with National Highway Infrastructure; shares up 7%

Premium

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Also Read

LIVE: SAD sends legal notice to CBFC over Kangana's movie Emergency, seeks to prevent release

Google releases Gmail Q&A feature on Android, coming soon to iOS: Know more

Garden Reach inks MoU with National Highway Infrastructure; shares up 7%

India spends more than 3% of GDP on govt pensions, states' burden growing

Google permits playlist sharing from YouTube Music to Apple Music: How-to